Hematology Advisor

Latest

Orca-T Improves Outcomes After Myeloablative Conditioning for Hematologic Malignancies

Camidanlumab Tesirine Appears Safe, Effective in Relapsed/Refractory Classical Hodgkin Lymphoma

Patients With Diffuse Large B-Cell Lymphoma May Benefit From Shared Decision Making Schemes

Disparities in Multiple Myeloma Diagnosis and Outcomes Identified in Hispanic Patients

Though Improved, Outcomes Remain Poor for Patients With MDS Who Progress on HMA Therapy

DOACs May Be a Viable Alternative to LMWH in Venous Thromboembolism

Safety Profile of Isatuximab Confirmed in Real-World Study of Patients With Multiple Myeloma

Improvement in Hemoglobin and LDH Is Rapid With Pegcetacoplan in PNH

Asciminib Improves MMR, Toxicity Compared With Bosutinib in CML-CP

Zanubrutinib Appears Superior to Ibrutinib in Patients With Relapsed/Refractory CLL/SLL

Azacitidine May Improve Outcomes in a Subset of Patients With AML

Midostaurin Maintenance Improved Survival in FLT3-Mutated Acute Myeloid Leukemia

Detection of FLT3-ITD MRD Is Associated With Relapse and Death in AML

Advocating for Full Practice Authority: Do’s and Don’ts

Expert provides strategies for advocating for APRN full practice authority by presenting the health equity case and business case.

Acupuncture and Moxibustion for Insomnia Relief in Cancer Patients

Acupuncture and moxibustion, which are sometimes used together, have shown promise in reducing insomnia in patients with cancer.

ACCP Updates Guideline for Perioperative Management of Antithrombotic Therapy

New topics in the ACCP guideline include the perioperative management of patients receiving direct oral anticoagulants and P2Y12 inhibitor antiplatelet drugs.

Oral Anticancer Drugs Place High Financial Burden on Medicare Recipients

New data highlight the high cost of targeted oral anticancer medicines for patients with Medicare Part D coverage.

Browse drugs by:

Brand Generic Disease